hydroxychloroquine has been researched along with Stomach Neoplasms in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sec62 promotes GC metastasis by activating autophagy and subsequently regulating TIMP-1 and MMP2/9 balance." | 1.72 | Sec62 promotes gastric cancer metastasis through mediating UPR-induced autophagy activation. ( Chu, Y; Jiang, MZ; Jin, YR; Li, XF; Liang, J; Lin, JC; Shi, YT; Su, S; Wu, N; Xu, B; Zhou, H, 2022) |
| "Gastric cancer is an important cancer type worldwide, the anti‑angiogenic agent BC001 can target the vascular endothelial growth factor receptor 2 (VEGFR2), and significantly suppresses the growth of gastric cancer BGC823 cells in vitro and in vivo." | 1.51 | Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer. ( Fang, Q; Gao, F; Jiang, J; Liu, L; Tan, X; Wang, W; Xuan, ZX; Yang, X; Ye, Q; Ye, Z; Zhang, G; Zhou, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Su, S | 1 |
| Shi, YT | 1 |
| Chu, Y | 1 |
| Jiang, MZ | 1 |
| Wu, N | 1 |
| Xu, B | 1 |
| Zhou, H | 1 |
| Lin, JC | 1 |
| Jin, YR | 1 |
| Li, XF | 1 |
| Liang, J | 1 |
| Slopovský, J | 1 |
| Šálek, T | 1 |
| Pazderová, N | 1 |
| Zomborská, E | 1 |
| Makovník, M | 1 |
| Palacka, P | 1 |
| Horniczká, K | 1 |
| Stankovič, I | 1 |
| Pörsök, Š | 1 |
| Wang, W | 1 |
| Liu, L | 1 |
| Zhou, Y | 1 |
| Ye, Q | 1 |
| Yang, X | 1 |
| Jiang, J | 1 |
| Ye, Z | 1 |
| Gao, F | 1 |
| Tan, X | 1 |
| Zhang, G | 1 |
| Fang, Q | 1 |
| Xuan, ZX | 1 |
3 other studies available for hydroxychloroquine and Stomach Neoplasms
| Article | Year |
|---|---|
Sec62 promotes gastric cancer metastasis through mediating UPR-induced autophagy activation.
Topics: Adult; Aged; Aged, 80 and over; Animals; Autophagy; Cell Line, Tumor; eIF-2 Kinase; Female; Humans; | 2022 |
The first cancer patient with COVID-19 in Slovakia.
Topics: Adenocarcinoma; Aged; Azithromycin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug | 2020 |
Hydroxychloroquine enhances the antitumor effects of BC001 in gastric cancer.
Topics: Animals; Antibodies, Monoclonal; Antimalarials; Apoptosis; Cell Proliferation; Drug Synergism; Femal | 2019 |